Oculis Holding AG (OCS) Gains from Investment Securities (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Gains from Investment Securities came in at $10.2 million in Q1 2026, down 23.05% year-on-year from $13.2 million in Q1 2025, and up 150.86% quarter-over-quarter from $4.1 million in Q4 2025.

Oculis Holding AG (OCS) Gains from Investment Securities (2023 - 2026) Analysis & Trends

Oculis Holding AG's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $10.2 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 23.05% year-over-year to $10.2 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 61.25% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, down 16.01% from the prior year.
  • Gains from Investment Securities climbed to $10.2 million in Q1 2026 per OCS's latest filing, from $4.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $15.3 million in Q4 2024 and bottomed at -$3.9 million in Q3 2025.
  • The 4-year median for Gains from Investment Securities is $2.8 million (2023), against an average of $3.5 million.
  • Across the five-year window, Gains from Investment Securities jumped 1223.05% in 2024 and sank 854.27% in 2025, its largest moves.
  • Year by year, Gains from Investment Securities stood at -$1.4 million in 2023, then soared by 1223.05% to $15.3 million in 2024, then slumped by 73.41% to $4.1 million in 2025, then soared by 150.86% to $10.2 million in 2026.
  • Per Business Quant, the three latest OCS Gains from Investment Securities figures stand at $10.2 million (Q1 2026), $4.1 million (Q4 2025), and -$3.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.19 Mn
Mar 31, 2026 10.19 Mn
Dec 31, 2025 4.06 Mn
Dec 31, 2025 4.06 Mn
Sep 30, 2025 -3.87 Mn
Sep 30, 2025 -3.87 Mn
Jun 30, 2025 282,646.31
Jun 30, 2025 282,646.31
Mar 31, 2025 13.25 Mn
Mar 31, 2025 13.25 Mn
Dec 31, 2024 15.28 Mn
Dec 31, 2024 15.28 Mn
Sep 30, 2024 513,622.22
Sep 30, 2024 513,622.22
Jun 30, 2024 -1.51 Mn
Jun 30, 2024 -1.51 Mn
Mar 31, 2024 3.52 Mn
Mar 31, 2024 3.52 Mn
Dec 31, 2023 -1.36 Mn
Dec 31, 2023 -1.36 Mn